Showing: 1 - 1 of 1 RESULTS
Announcements Banner News Niemann-Pick Type C News Research News

Bloomsbury Genetic Therapies Outlines Pre-Clinical Data on CNS Programs including NPC

London, UK, 18 May 2023 – Bloomsbury Genetic Therapies Limited, a clinical-stage biotechnology company developing potentially curative treatments for patients suffering from rare neurological and metabolic diseases based on clinically proven gene therapy technologies, announced today that pre-clinical data from two of its brain-targeted programs, BGT-INAD and BGT-NPC for the treatment of Infantile Neuroaxonal Dystrophy …